Anzeige
Meldung des Tages: Freitagabend nachbörslich veröffentlicht – was der Markt erst am Montag sieht

BeOne Medicines Aktie (ADR) News

Aktie
WKN:  A1437N ISIN:  US07725L1026 US-Symbol:  ONC Branche:  Biotechnologie Land:  Schweiz
340,46 $
-9,54 $
-2,73%
287,30 € 30.01.26
Depot/Watchlist
Marktkapitalisierung *
28,99 Mrd. €
Streubesitz
51,65%
KGV
91,18
Faktor
0.0769231
Originalaktie
CH1391448177
neu: Nachhaltigkeits-Score
20 %
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,44: MM2KYV
Werbung

BeOne Medicines Aktie (ADR) News

02.02.25 - Börse-Global
BeiGene Aktie: Erfolgsgeheimnis gelüftet
Die BeiGene-​Aktie zeigt zu Beginn des Jahres 2025 eine bemerkenswerte Dynamik an den Börsen. Mit einer aktuellen Marktkapitalisierung von 21,2 Milliarden Euro verzeichnete ...
22.01.25 - PR Newswire
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium PR Newswire
22.01.25 - PR Newswire
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium PR Newswire
22.01.25 - PR Newswire
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium
Oncolytics Biotech® to Present Compelling New Efficacy and Safety Data in Anal and Pancreatic Cancers at 2025 ASCO GI Symposium PR Newswire
15.01.25 - PR Newswire
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data
Regulatory Approval Clears Path for Oncolytics Biotech® to Advance Promising Pancreatic Cancer Treatment, Following a Review of Safety Data PR Newswire
19.11.24 - PR Newswire
Labcorp CFO Glenn Eisenberg Announces Plans to Retire
Labcorp CFO Glenn Eisenberg Announces Plans to Retire PR Newswire
13.03.24 - PR Newswire
Thinking about trading options or stock in NVIDIA, Tesla, Oracle, Broadcom, or Beigene?
Thinking about trading options or stock in NVIDIA, Tesla, Oracle, Broadcom, or Beigene? PR Newswire
30.10.23 - PR Newswire
Thinking about trading options or stock in NVIDIA, Apple, JinkoSolar, Beigene, or Netflix?
Thinking about trading options or stock in NVIDIA, Apple, JinkoSolar, Beigene, or Netflix? PR Newswire
11.09.23 - PR Newswire
Thinking about trading options or stock in Hostess Brands Inc, Beigene Ltd, Xpeng Inc - ADR, Enbridge Inc, or Docusign Inc?
Thinking about trading options or stock in Hostess Brands Inc, Beigene Ltd, Xpeng Inc - ADR, Enbridge Inc, or Docusign Inc? PR Newswire
30.06.23 - PR Newswire
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE PR Newswire
23.06.23 - PR Newswire
BGNE LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE
BGNE LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BeiGene, Ltd. Investors to Inquire About Securities Class Action Investigation - BGNE PR Newswire
15.06.23 - PR Newswire
Thinking about trading options or stock in Plug Power, Microvision, Beigene, Zai Lab, or NVIDIA?
Thinking about trading options or stock in Plug Power, Microvision, Beigene, Zai Lab, or NVIDIA? PR Newswire
08.12.22 - PR Newswire
Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in combination with Tislelizumab
Phanes Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate PT199 in combination with Tislelizumab PR Newswire
12.07.22 - PR Newswire
Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer
Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer PR Newswire

Newssuche

Videos

newspaper
29.01.26 -10,12%
Rekordjagd bei Gold! Februar Ausblick & Forecast
Ab 2.2. (Montag) börsentäglich um 18 Uhr FEIERABEND-​TRADING. Echte Trades, strategiebasiert, ... Mehr »